Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements
Launched by MAYO CLINIC · May 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to test a new digital device that measures how well people can see, called visual acuity, and compare it to the standard way we currently measure it. The goal is to see if the new device is just as accurate. Additionally, the researchers want to collect recordings of letters spoken aloud to help create a system that can recognize these letters when they are spoken.
To participate in this trial, you must be an adult aged 18 and older and willing to give your consent to take part. Unfortunately, those under 18 or unable to give consent cannot join. If you decide to participate, you will help us understand how well this new device works and could contribute to advancements in eye care technology. Right now, the trial is not yet recruiting participants, but it's an exciting opportunity for those who qualify.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥ 18 years) who come to Ophthalmology Clinic.
- • Willing and able to provide consent.
- Exclusion Criteria:
- • Individuals \< 18 years of age.
- • Unable to provide consent.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jacksonville, Florida, United States
Patients applied
Trial Officials
Antonio Forte, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported